Compare ARK Genomic Revolution ETF (ARKG) vs Taskus Inc (TASK) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Taskus Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.96, while Taskus Inc trades at $5.46 (market cap $495.44M). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Taskus Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | TASK | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $18.21 |
52-Week Low | $23.09 | $4.57 |
Market Cap | — | $495.44M |
Enterprise Value | — | $891.14M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
TaskUs (TASK) trades at $5.41, up 2.66% today, with a neutral technical signal and bearish moving averages. The company shows strong fundamentals with a P/E of 4.79 and net income margin of 8.7%, while recent Q1 2026 earnings missed expectations. Revenue grew to $1.18 billion in 2025, and the company appointed a new CFO in June 2026.
The stock appears undervalued with a consensus price target of $9.50, offering significant upside potential. However, risks include recent earnings miss, competitive pressures in digital services, and potential market volatility. Analyst sentiment is mixed with 55% buy ratings but cautious technical indicators.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Taskus Inc
TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to innovative and disruptive technology companies. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.
Read more on TASK →
